Literature DB >> 10070023

Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes.

C D Mamotte1, M Sturm, J I Foo, F M van Bockxmeer, R R Taylor.   

Abstract

Compared with apolipoprotein E3 (apoE3), apoE2 is less effective in mediating the binding of lipoproteins to the low-density lipoprotein (LDL) receptor. The influence of the E4 isoform, which is associated with adverse effects on plasma lipids and coronary heart disease, is less clear. We compared the ability of very low density lipoprotein (VLDL) and LDL from paired E4/4 and E3/3 subjects to compete against 125I-labeled LDL for binding with the LDL receptor on cultured fibroblasts and Hep G2 cells. The concentrations of VLDL or LDL required to inhibit binding of 125I-LDL by 50% (IC50, microgram apoB/ml) were determined, and results were assessed in terms of an IC50 ratio, E4/4 IC50 relative to E3/3 IC50, to reduce the influence of interassay variability. In Hep G2 cells, E4/4 VLDL was more effective than E3/3 VLDL in competing for the LDL receptor, the IC50 ratio being lower than unity (0.73 +/- 0.31, P < 0.05, two-tailed t-test). IC50 values themselves were marginally lower in E4/4 than E3/3 subjects (3.7 +/- 1.3 vs. 6.1 +/- 3.7, P < 0.08). However, there was no difference between E4/4 and E3/3 VLDL in competing for the LDL receptor on fibroblasts or between E4/4 and E3/3 LDL in competing for the LDL receptor on either cell type. These results suggest that inheritance of apoE4 is associated with an increased affinity of VLDL particles for LDL receptors on hepatocytes and may partly explain the influence of the E4 isoform on lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070023     DOI: 10.1152/ajpendo.1999.276.3.E553

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

1.  Conformational analysis of apolipoprotein E3/E4 heteromerization.

Authors:  Kai-Han Tu; Devan Abhari; Vasanthy Narayanaswami
Journal:  FEBS J       Date:  2019-03-13       Impact factor: 5.542

2.  Apolipoprotein E4 domain interaction accelerates diet-induced atherosclerosis in hypomorphic Arg-61 apoe mice.

Authors:  Delphine Eberlé; Roy Y Kim; Fu Sang Luk; Nabora Soledad Reyes de Mochel; Nathalie Gaudreault; Victor R Olivas; Nikit Kumar; Jessica M Posada; Andrew C Birkeland; Joseph H Rapp; Robert L Raffai
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-22       Impact factor: 8.311

3.  Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients.

Authors:  Patrick M Moriarty; Stephen A Varvel; Philip L S M Gordts; Joseph P McConnell; Sotirios Tsimikas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-01-05       Impact factor: 8.311

4.  Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid.

Authors:  Panupon Khumsupan; Ricardo Ramirez; Darin Khumsupan; Vasanthy Narayanaswami
Journal:  Biochim Biophys Acta       Date:  2010-09-17

5.  Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.

Authors:  Yu-Wen Alvin Huang; Bo Zhou; Amber M Nabet; Marius Wernig; Thomas C Südhof
Journal:  J Neurosci       Date:  2019-07-22       Impact factor: 6.167

6.  Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice.

Authors:  Michael Altenburg; Jose Arbones-Mainar; Lance Johnson; Jennifer Wilder; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-27       Impact factor: 8.311

7.  Apolipoprotein E and cholesterol in aging and disease in the brain.

Authors:  Elena Posse de Chaves; Vasanthy Narayanaswami
Journal:  Future Lipidol       Date:  2008-10

8.  Association of polymorphisms at restriction enzyme recognition sites of apolipoprotein B and E gene with dyslipidemia in children undergoing primary nephrotic syndrome.

Authors:  Peng Hu; Yuan Han Qin; Cheng Xue Jing; Feng Ying Lei; Ping Chen; Ming Fang Li
Journal:  Mol Biol Rep       Date:  2008-05-30       Impact factor: 2.316

Review 9.  Lipids and HCV.

Authors:  M F Bassendine; D A Sheridan; S H Bridge; D J Felmlee; R D G Neely
Journal:  Semin Immunopathol       Date:  2012-10-31       Impact factor: 9.623

10.  Mathematical model for low density lipoprotein (LDL) endocytosis by hepatocytes.

Authors:  J A D Wattis; B O'Malley; H Blackburn; L Pickersgill; J Panovska; H M Byrne; K G Jackson
Journal:  Bull Math Biol       Date:  2008-08-21       Impact factor: 1.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.